View ValuationTKG Huchems 将来の成長Future 基準チェック /06TKG Huchems利益と収益がそれぞれ年間2.6%と4.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に7.5% 0.7%なると予測されています。主要情報2.6%収益成長率0.69%EPS成長率Chemicals 収益成長67.0%収益成長率4.8%将来の株主資本利益率7.48%アナリストカバレッジLow最終更新日02 Jun 2026今後の成長に関する最新情報Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.すべての更新を表示Recent updatesお知らせ • Apr 24TKG Huchems Co., Ltd. announced that it has received KRW 50 billion in funding from J&Alpha Co., LtdOn April 23, 2026, TKG Huchems Co., Ltd. has closed the transaction.お知らせ • Apr 10TKG Huchems Co., Ltd. announced that it expects to receive KRW 50 billion in funding from J&Alpha Co., LtdTKG Huchems Co., Ltd. announced a private placement of series 4 unsecured privately placed exchangeable bond with bearer interest for gross proceeds of KRW 50,000,000,000 on April 8, 2026. The transaction will include participation from a new investor, J&Alpha Co., Ltd. for KRW 50,000,000,000. The bond has a maturity interest rate of 1% and will mature on April 23, 2031. The bonds are fully convertible into 2,819,283 common shares of the company at a conversion price of KRW 17,735 per share. The bonds can be converted between April 24, 2027 and March 23, 2031. The transaction is expected to close on April 23, 2026. The subscription date is April 23, 2026. The transaction has been approved by the board of directors of the company on April 8, 2026.Reported Earnings • Mar 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₩1,561 (down from ₩2,024 in FY 2024). Revenue: ₩1.13t (down 5.1% from FY 2024). Net income: ₩59.9b (down 23% from FY 2024). Profit margin: 5.3% (down from 6.5% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.お知らせ • Feb 27TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South KoreaPrice Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.Upcoming Dividend • Feb 19Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 26 February 2026. Payment date: 24 April 2026. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.2%).分析記事 • Nov 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. Our...New Risk • Nov 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.分析記事 • May 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsThe subdued market reaction suggests that TKG Huchems Co., Ltd.'s ( KRX:069260 ) recent earnings didn't contain any...Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.New Risk • Mar 19New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin).Reported Earnings • Mar 19Full year 2024 earnings: EPS in line with analyst expectations despite revenue beatFull year 2024 results: EPS: ₩2,024 (down from ₩3,512 in FY 2023). Revenue: ₩1.19t (up 13% from FY 2023). Net income: ₩77.7b (down 42% from FY 2023). Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Feb 21TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South KoreaPrice Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 5.4%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).分析記事 • Nov 22TKG Huchems' (KRX:069260) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. We...お知らせ • Aug 28TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion.TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion on August 27, 2024. A cash consideration of KRW 60.33 billion will be paid by TKG Huchems for 502,721 shares. The expected completion of the transaction is August 28, 2024.Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.New Risk • Jul 22New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.分析記事 • Mar 21TKG Huchems' (KRX:069260) Solid Earnings May Rest On Weak FoundationsThe recent earnings posted by TKG Huchems Co., Ltd. ( KRX:069260 ) were solid, but the stock didn't move as much as we...Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.お知らせ • Feb 22TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024, at 09:01 Korea Standard Time. Location: Namsan Square 19F, Toegyero 173, Junggu Seoul South Korea Agenda: To report Business Report, to consider audit Report; to consider Internal Accounting Control System Report; to consider approval of Financial Statements for the 22nd Term; to consider election of directors; to consider election of Executive Directors; to consider approval of ceiling amount for the remuneration onto Directors; and to consider approval of ceiling amount for the remuneration onto Auditor.Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per share at 4.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).New Risk • Oct 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Major Estimate Revision • May 25Consensus revenue estimates decrease by 10%, EPS upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩1.04b to ₩939.0m. EPS estimate increased from ₩2,449 to ₩2,939 per share. Net income forecast to grow 29% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩29,000 to ₩31,000. Share price was steady at ₩23,350 over the past week.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩21,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years.Major Estimate Revision • Jan 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₩1.21b to ₩1.23b. EPS estimate fell from ₩2,643 to ₩2,373 per share. Net income forecast to grow 25% next year vs 25% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩32,500 to ₩29,500. Share price was steady at ₩19,600 over the past week.Upcoming Dividend • Dec 21Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 24% over the past three years.Major Estimate Revision • Jul 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩3,370 to ₩2,842 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 46% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price fell 8.0% to ₩18,300 over the past week.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Upcoming Dividend • Dec 22Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).Price Target Changed • Dec 10Price target increased to ₩30,750Up from ₩27,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩23,750. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₩2,281 for next year compared to ₩1,292 last year.Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩27,450, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩31,191 per share.Major Estimate Revision • May 14Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩2,209 to ₩2,466. Revenue forecast steady at ₩772.0m. Net income forecast to grow 92% next year vs 87% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩27,750 unchanged from last update. Share price was steady at ₩21,900 over the past week.分析記事 • May 05Is Huchems Fine Chemical (KRX:069260) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Apr 01Investors Will Want Huchems Fine Chemical's (KRX:069260) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Reported Earnings • Mar 20Full year 2020 earnings released: EPS ₩1,292 (vs ₩1,812 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩593.5b (down 10.0% from FY 2019). Net income: ₩49.6b (down 30% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.分析記事 • Mar 17Is Huchems Fine Chemical Corporation (KRX:069260) Popular Amongst Institutions?The big shareholder groups in Huchems Fine Chemical Corporation ( KRX:069260 ) have power over the company...Is New 90 Day High Low • Mar 10New 90-day low: ₩21,300The company is down 11% from its price of ₩23,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,740 per share.分析記事 • Mar 02Are Huchems Fine Chemical Corporation's (KRX:069260) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?It is hard to get excited after looking at Huchems Fine Chemical's (KRX:069260) recent performance, when its stock has...お知らせ • Feb 27Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.分析記事 • Feb 15Here's What You Should Know About Huchems Fine Chemical Corporation's (KRX:069260) 4.2% Dividend YieldDividend paying stocks like Huchems Fine Chemical Corporation ( KRX:069260 ) tend to be popular with investors, and for...Major Estimate Revision • Feb 12Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate was lowered from ₩1,764 to ₩1,543. No change was made to the revenue estimate which at the last update was ₩590.1m. Net income is expected to grow by 72% next year compared to 60% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩30,000 was unchanged from the last update. Share price stayed mostly flat at ₩22,550 over the past week.Price Target Changed • Feb 03Price target raised to ₩30,000Up from ₩24,250, the current price target is an average from 2 analysts. The new target price is 28% above the current share price of ₩23,450. As of last close, the stock is up 22% over the past year.分析記事 • Feb 01Huchems Fine Chemical (KRX:069260) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Is New 90 Day High Low • Jan 29New 90-day low: ₩21,400The company is down 7.0% from its price of ₩22,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,786 per share.分析記事 • Jan 19Huchems Fine Chemical (KRX:069260) Has Compensated Shareholders With A Respectable 89% Return On Their InvestmentIf you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...分析記事 • Jan 06Does Huchems Fine Chemical's (KRX:069260) Statutory Profit Adequately Reflect Its Underlying Profit?As a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...Price Target Changed • Dec 30Price target raised to ₩25,000Up from ₩23,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩25,650. As of last close, the stock is up 21% over the past year.分析記事 • Dec 24Huchems Fine Chemical Corporation (KRX:069260) Goes Ex-Dividend SoonHuchems Fine Chemical Corporation ( KRX:069260 ) stock is about to trade ex-dividend in 3 days. You can purchase shares...Upcoming Dividend • Dec 22Upcoming Dividend of ₩1,000 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%).分析記事 • Dec 13What Is The Ownership Structure Like For Huchems Fine Chemical Corporation (KRX:069260)?A look at the shareholders of Huchems Fine Chemical Corporation ( KRX:069260 ) can tell us which group is most...分析記事 • Nov 29Is Huchems Fine Chemical Corporation's (KRX:069260) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Huchems Fine Chemical's (KRX:069260) stock is up by a considerable 36% over the past three months. Given that stock...Major Estimate Revision • Nov 12Analysts lower revenue estimates to ₩585.8mThe 2020 consensus revenue estimate decreased from ₩675.0m. Earning per share (EPS) estimate was also lowered from ₩1,915 to ₩1,792 for the same period. Net income is expected to grow by 24% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target increased from ₩23,250 to ₩24,250. Share price is up 8.5% to ₩24,900 over the past week.Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to ₩25,900, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 25%.Price Target Changed • Nov 10Price target raised to ₩24,250Up from ₩21,900, the current price target is an average from 4 analysts. The new target price is 6.9% below the current share price of ₩26,050. As of last close, the stock is up 16% over the past year.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₩27,150, the stock is trading at a trailing P/E ratio of 16.7x, up from the previous P/E ratio of 14.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 34%.Is New 90 Day High Low • Nov 09New 90-day high: ₩27,150The company is up 66% from its price of ₩16,400 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩13,972 per share.業績と収益の成長予測KOSE:A069260 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281,321,95061,85099,400114,700212/31/20271,352,80074,45096,200122,600212/31/20261,295,30065,00090,60098,00013/31/20261,153,31859,39786,65998,377N/A12/31/20251,127,69159,90790,436102,429N/A9/30/20251,163,14469,09198,157111,482N/A6/30/20251,166,17358,61642,81264,654N/A3/31/20251,156,69261,67641,57567,083N/A12/31/20241,188,23977,65545,51979,257N/A9/30/20241,097,50689,85032,99176,880N/A6/30/20241,039,724101,15366,498142,601N/A3/31/20241,038,946120,044103,206189,275N/A12/31/20231,052,689134,775107,314221,566N/A9/30/20231,133,033118,93557,228189,106N/A6/30/20231,247,813118,7056,286127,047N/A3/31/20231,256,18699,989-34,73388,609N/A12/31/20221,235,83881,708-47,80144,370N/A3/31/2022979,14679,55567,37294,918N/A12/31/2021861,20575,66061,58383,804N/A9/30/2021771,25465,53956,66375,452N/A6/30/2021678,79663,44158,72577,161N/A3/31/2021590,03648,83564,08879,043N/A12/31/2020593,51149,58768,79990,694N/A9/30/2020604,61448,18360,96788,529N/A6/30/2020645,17262,27256,46592,223N/A3/31/2020672,01072,93551,08089,032N/A12/31/2019659,77370,358N/A107,283N/A9/30/2019665,67375,749N/A95,462N/A6/30/2019689,46580,125N/A110,203N/A3/31/2019738,85995,584N/A121,828N/A12/31/2018762,875104,498N/A116,631N/A9/30/2018757,233115,653N/A139,669N/A6/30/2018735,245112,967N/A164,852N/A3/31/2018719,506114,392N/A166,578N/A12/31/2017715,765114,391N/A156,381N/A9/30/2017702,262104,315N/A169,310N/A6/30/2017676,65188,226N/A124,629N/A3/31/2017648,22668,733N/A118,796N/A12/31/2016598,23243,116N/A115,486N/A9/30/2016601,98541,586N/A94,651N/A6/30/2016596,07734,050N/A78,606N/A3/31/2016576,18827,767N/A87,100N/A12/31/2015600,42636,632N/A66,496N/A9/30/2015647,82438,865N/A97,113N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A069260の予測収益成長率 (年間2.6% ) は 貯蓄率 ( 3.1% ) を下回っています。収益対市場: A069260の収益 ( 2.6% ) KR市場 ( 32% ) よりも低い成長が予測されています。高成長収益: A069260の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: A069260の収益 ( 4.8% ) KR市場 ( 16% ) よりも低い成長が予測されています。高い収益成長: A069260の収益 ( 4.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A069260の 自己資本利益率 は、3年後には低くなると予測されています ( 7.5 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/20 22:54終値2026/07/20 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋TKG Huchems Co., Ltd. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14 アナリスト機関Jae Sung YoonDaishin Securities Co. Ltd.Ji Hwan YangDaishin Securities Co. Ltd.Hee Cheol LeeDAOL Investment & Securities Co., Ltd.11 その他のアナリストを表示
Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.
Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.
Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.
Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.
Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.
Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.
お知らせ • Apr 24TKG Huchems Co., Ltd. announced that it has received KRW 50 billion in funding from J&Alpha Co., LtdOn April 23, 2026, TKG Huchems Co., Ltd. has closed the transaction.
お知らせ • Apr 10TKG Huchems Co., Ltd. announced that it expects to receive KRW 50 billion in funding from J&Alpha Co., LtdTKG Huchems Co., Ltd. announced a private placement of series 4 unsecured privately placed exchangeable bond with bearer interest for gross proceeds of KRW 50,000,000,000 on April 8, 2026. The transaction will include participation from a new investor, J&Alpha Co., Ltd. for KRW 50,000,000,000. The bond has a maturity interest rate of 1% and will mature on April 23, 2031. The bonds are fully convertible into 2,819,283 common shares of the company at a conversion price of KRW 17,735 per share. The bonds can be converted between April 24, 2027 and March 23, 2031. The transaction is expected to close on April 23, 2026. The subscription date is April 23, 2026. The transaction has been approved by the board of directors of the company on April 8, 2026.
Reported Earnings • Mar 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₩1,561 (down from ₩2,024 in FY 2024). Revenue: ₩1.13t (down 5.1% from FY 2024). Net income: ₩59.9b (down 23% from FY 2024). Profit margin: 5.3% (down from 6.5% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.
お知らせ • Feb 27TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea
Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.
Upcoming Dividend • Feb 19Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 26 February 2026. Payment date: 24 April 2026. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.2%).
分析記事 • Nov 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. Our...
New Risk • Nov 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
分析記事 • May 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsThe subdued market reaction suggests that TKG Huchems Co., Ltd.'s ( KRX:069260 ) recent earnings didn't contain any...
Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.
New Risk • Mar 19New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin).
Reported Earnings • Mar 19Full year 2024 earnings: EPS in line with analyst expectations despite revenue beatFull year 2024 results: EPS: ₩2,024 (down from ₩3,512 in FY 2023). Revenue: ₩1.19t (up 13% from FY 2023). Net income: ₩77.7b (down 42% from FY 2023). Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Feb 21TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea
Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.
Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 5.4%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).
分析記事 • Nov 22TKG Huchems' (KRX:069260) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. We...
お知らせ • Aug 28TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion.TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion on August 27, 2024. A cash consideration of KRW 60.33 billion will be paid by TKG Huchems for 502,721 shares. The expected completion of the transaction is August 28, 2024.
Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.
Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.
New Risk • Jul 22New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
分析記事 • Mar 21TKG Huchems' (KRX:069260) Solid Earnings May Rest On Weak FoundationsThe recent earnings posted by TKG Huchems Co., Ltd. ( KRX:069260 ) were solid, but the stock didn't move as much as we...
Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.
お知らせ • Feb 22TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024, at 09:01 Korea Standard Time. Location: Namsan Square 19F, Toegyero 173, Junggu Seoul South Korea Agenda: To report Business Report, to consider audit Report; to consider Internal Accounting Control System Report; to consider approval of Financial Statements for the 22nd Term; to consider election of directors; to consider election of Executive Directors; to consider approval of ceiling amount for the remuneration onto Directors; and to consider approval of ceiling amount for the remuneration onto Auditor.
Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per share at 4.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
New Risk • Oct 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Major Estimate Revision • May 25Consensus revenue estimates decrease by 10%, EPS upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩1.04b to ₩939.0m. EPS estimate increased from ₩2,449 to ₩2,939 per share. Net income forecast to grow 29% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩29,000 to ₩31,000. Share price was steady at ₩23,350 over the past week.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩21,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years.
Major Estimate Revision • Jan 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₩1.21b to ₩1.23b. EPS estimate fell from ₩2,643 to ₩2,373 per share. Net income forecast to grow 25% next year vs 25% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩32,500 to ₩29,500. Share price was steady at ₩19,600 over the past week.
Upcoming Dividend • Dec 21Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 24% over the past three years.
Major Estimate Revision • Jul 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩3,370 to ₩2,842 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 46% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price fell 8.0% to ₩18,300 over the past week.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Upcoming Dividend • Dec 22Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).
Price Target Changed • Dec 10Price target increased to ₩30,750Up from ₩27,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩23,750. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₩2,281 for next year compared to ₩1,292 last year.
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩27,450, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩31,191 per share.
Major Estimate Revision • May 14Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩2,209 to ₩2,466. Revenue forecast steady at ₩772.0m. Net income forecast to grow 92% next year vs 87% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩27,750 unchanged from last update. Share price was steady at ₩21,900 over the past week.
分析記事 • May 05Is Huchems Fine Chemical (KRX:069260) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Apr 01Investors Will Want Huchems Fine Chemical's (KRX:069260) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Reported Earnings • Mar 20Full year 2020 earnings released: EPS ₩1,292 (vs ₩1,812 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩593.5b (down 10.0% from FY 2019). Net income: ₩49.6b (down 30% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
分析記事 • Mar 17Is Huchems Fine Chemical Corporation (KRX:069260) Popular Amongst Institutions?The big shareholder groups in Huchems Fine Chemical Corporation ( KRX:069260 ) have power over the company...
Is New 90 Day High Low • Mar 10New 90-day low: ₩21,300The company is down 11% from its price of ₩23,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,740 per share.
分析記事 • Mar 02Are Huchems Fine Chemical Corporation's (KRX:069260) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?It is hard to get excited after looking at Huchems Fine Chemical's (KRX:069260) recent performance, when its stock has...
お知らせ • Feb 27Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.
分析記事 • Feb 15Here's What You Should Know About Huchems Fine Chemical Corporation's (KRX:069260) 4.2% Dividend YieldDividend paying stocks like Huchems Fine Chemical Corporation ( KRX:069260 ) tend to be popular with investors, and for...
Major Estimate Revision • Feb 12Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate was lowered from ₩1,764 to ₩1,543. No change was made to the revenue estimate which at the last update was ₩590.1m. Net income is expected to grow by 72% next year compared to 60% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩30,000 was unchanged from the last update. Share price stayed mostly flat at ₩22,550 over the past week.
Price Target Changed • Feb 03Price target raised to ₩30,000Up from ₩24,250, the current price target is an average from 2 analysts. The new target price is 28% above the current share price of ₩23,450. As of last close, the stock is up 22% over the past year.
分析記事 • Feb 01Huchems Fine Chemical (KRX:069260) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Is New 90 Day High Low • Jan 29New 90-day low: ₩21,400The company is down 7.0% from its price of ₩22,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,786 per share.
分析記事 • Jan 19Huchems Fine Chemical (KRX:069260) Has Compensated Shareholders With A Respectable 89% Return On Their InvestmentIf you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
分析記事 • Jan 06Does Huchems Fine Chemical's (KRX:069260) Statutory Profit Adequately Reflect Its Underlying Profit?As a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...
Price Target Changed • Dec 30Price target raised to ₩25,000Up from ₩23,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩25,650. As of last close, the stock is up 21% over the past year.
分析記事 • Dec 24Huchems Fine Chemical Corporation (KRX:069260) Goes Ex-Dividend SoonHuchems Fine Chemical Corporation ( KRX:069260 ) stock is about to trade ex-dividend in 3 days. You can purchase shares...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩1,000 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%).
分析記事 • Dec 13What Is The Ownership Structure Like For Huchems Fine Chemical Corporation (KRX:069260)?A look at the shareholders of Huchems Fine Chemical Corporation ( KRX:069260 ) can tell us which group is most...
分析記事 • Nov 29Is Huchems Fine Chemical Corporation's (KRX:069260) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Huchems Fine Chemical's (KRX:069260) stock is up by a considerable 36% over the past three months. Given that stock...
Major Estimate Revision • Nov 12Analysts lower revenue estimates to ₩585.8mThe 2020 consensus revenue estimate decreased from ₩675.0m. Earning per share (EPS) estimate was also lowered from ₩1,915 to ₩1,792 for the same period. Net income is expected to grow by 24% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target increased from ₩23,250 to ₩24,250. Share price is up 8.5% to ₩24,900 over the past week.
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to ₩25,900, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 25%.
Price Target Changed • Nov 10Price target raised to ₩24,250Up from ₩21,900, the current price target is an average from 4 analysts. The new target price is 6.9% below the current share price of ₩26,050. As of last close, the stock is up 16% over the past year.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₩27,150, the stock is trading at a trailing P/E ratio of 16.7x, up from the previous P/E ratio of 14.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 34%.
Is New 90 Day High Low • Nov 09New 90-day high: ₩27,150The company is up 66% from its price of ₩16,400 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩13,972 per share.